Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what the latest date is by which all manufacturers of Covid-19 vaccines used in the UK must meet the conditions of their Conditional Marketing Authorisations.
The following table shows the latest date by which manufacturers of COVID-19 vaccines used in the United Kingdom have a Conditional Marketing Authorisation.
Spikevax | 31 December 2023 |
Spikevax bivalent original/Omicron BA.1 | 30 September 2024 |
Nuvaxovid | 31 January 2023 |
Vaxzevria | 31 March 2024 |